Qualifying Conditions in State Medical Cannabis Programs

The Association of Cannabinoid Specialists (ACS) asserts that rigid lists of qualifying conditions for medical cannabis use are medically inappropriate and restrict access to evidence-based care. State laws that dictate which conditions are eligible for treatment with cannabis undermine the professional judgment of physicians and reduce the flexibility necessary to respond to evolving scientific evidence.

Clinical Expertise and Judgment

ACS advocates for a model in which licensed healthcare professionals determine medical necessity based on clinical expertise and patient-specific circumstances. This model is currently in practice in Massachusetts, where physicians are authorized to recommend cannabis for any condition they judge to be appropriate. We believe this represents the gold standard for patient care in cannabis medicine.

Conditions such as anxiety, depression, and insomnia—despite being common and often debilitating—are frequently excluded from qualifying lists. However, emerging evidence supports the therapeutic potential of cannabis for these conditions, when used under proper clinical supervision and with appropriate dosing protocols. Arbitrary legislative exclusions deny patients access to potentially beneficial treatments and restrict physicians from delivering individualized, science-informed care.

Fixed condition lists are inherently static and politicized. They fail to evolve with the scientific landscape and delay the integration of new knowledge into practice. A physician-led model, by contrast, ensures that patient care remains flexible, responsive, and rooted in current evidence.

Professional Accountability

Furthermore, medical cannabis should be used in a system that emphasizes clinical oversight and risk mitigation. Without appropriate physician engagement, patients are at greater risk for overuse, tolerance, and cannabis use disorder. Medical cannabis programs must be structured to avoid these pitfalls through evidence-based guidance, dosing control, and longitudinal patient monitoring. Similarly, physicians must be held accountable to their licensing boards to uphold evidence-driven standards of care in this field, as in all others.

Therefore, the Association of Cannabinoid Specialists calls on all states to eliminate restrictive qualifying condition lists and to implement policies that empower trained and licensed physicians to determine medical necessity. This approach ensures safe, effective, and equitable access to cannabis as a legitimate medical treatment and places the responsibility for medical decisions where it belongs—with clinicians who are accountable to their patients, licensing board, and the science.

– Association of Cannabinoid Specialists